Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
02/2014
02/11/2014CA2646383C Inhibitors of lethal factor protease of anthrax toxin
02/11/2014CA2631868C Treatment of drug-resistant tumors
02/11/2014CA2631343C The combination of omega-3 fatty acids and thyroid hormone for treating alzheimer's dementia
02/11/2014CA2631241C Materials and methods for treating viral infections with a cysteamine compound
02/11/2014CA2628971C Therapeutic or prophylactic agent for functional bowel disorder
02/11/2014CA2618110C Derivatives of 5-pyridazinyl-1-azabicyclo[3.2.1]octane, preparation method thereof and use of same in therapeutics
02/11/2014CA2617717C Use of tiotropium salts in the treatment of severe persistant asthma
02/11/2014CA2617312C Noninvasive measurement of chemical substances
02/11/2014CA2617002C Method of obtaining a natural hydroxytyrosol-rich concentrate from olive tree residues and subproducts using clean technologies
02/11/2014CA2611401C Oxindoles as kinase inhibitors
02/11/2014CA2610773C Clarithromycin or a salt thereof for use in the treatment or prevention of pulmonary disease induced by destruction of pulmonary alveoli
02/11/2014CA2607857C Inhibitors of cytosolic phospholipase a2
02/11/2014CA2606714C Non-lithotripsic kidney-stone therapy
02/11/2014CA2606650C Crystalline form of 1-chloro-4-(.beta.-d-glucopyranos-1-yl)-2-[4-((s)-tetrahydrofuran-3-yloxy)-benzyl]-benzene, a method for its preparation and the use thereof for preparing medicaments
02/11/2014CA2606471C Benzisoxazole piperidine compounds and methods of use thereof
02/11/2014CA2602066C Aloe vera extract, method of producing aloe vera extract, and hyperglycemia improving agent
02/11/2014CA2599643C Novel imidazo[1,5-a]pyridine derivatives, method for preparing same and pharmaceutical compositions containing same
02/11/2014CA2591089C Medicaments for the treatment or prevention of fibrotic diseases
02/11/2014CA2582247C 3-arylamino pyridine derivatives
02/11/2014CA2577702C New polymorphic form of inulin and uses thereof
02/11/2014CA2572864C Extended release tablet formulation containing pramipexole or a pharmaceutically acceptable salt thereof, method for manufacturing the same and use thereof
02/11/2014CA2572121C Pyrimido-benzimidazole derivatives and the use thereof in the form of agonists or antagonists of melanocortin receptors
02/11/2014CA2560042C Hmb compositions and uses thereof
02/11/2014CA2559187C Substituted phenoxy- and phenylthio- derivatives for treating proliferative disorders
02/11/2014CA2558513C Amorolfine patch for treating onychomycosis
02/11/2014CA2551749C Inhalant formulation containing sulfoalkyl ether cyclodextrin and corticosteroid
02/11/2014CA2549724C Use of treprostinil to treat and prevent ischemic lesions
02/11/2014CA2549662C A method for the production of enriched hop extracts having combined oestrogenic and antiproliferative bioactivity
02/11/2014CA2536622C Inhibitors of cellular necrosis
02/11/2014CA2529265C Quinoline derivatives for the treatment of latent tuberculosis
02/11/2014CA2524255C Modulation of exon recognition in pre-mrna by interfering with the secondary rna structure
02/11/2014CA2521655C Abuse-resistant oral dosage forms and method of use thereof
02/11/2014CA2511199C Small molecule modulators of hepatocyte growth factor (scatter factor) activity
02/11/2014CA2501506C Modulation of anxiety through blockade of anandamide hydrolysis
02/11/2014CA2493806C Aqueous iron carbohydrate complexes, their production and medicaments containing them
02/11/2014CA2477642C Formoterol tartrate process and polymorph
02/11/2014CA2471432C Nonhuman model animal lacking the ability to control lymphocyte migration
02/11/2014CA2466632C Injectable depot compositions and uses thereof
02/11/2014CA2437038C Method of determining a chemotherapeutic regimen based on ercc1 and ts expression
02/11/2014CA2421751C Muc1 extracellular domain and cancer treatment compositions and methods derived therefrom
02/11/2014CA2387184C Cell-permeable peptide inhibitors of the jnk signal transduction pathway
02/11/2014CA2357986C Acid stable backbone modified end-blocked nucleic acids and therapeutic uses thereof
02/11/2014CA2288330C Benzoyl amino acid derivatives useful as inhibitors of protein isoprenyl tranferases
02/06/2014WO2014022859A1 Antiparasitic compositions and methods
02/06/2014WO2014022858A1 Enzyme-activating compounds and compositions
02/06/2014WO2014022852A1 Cell-specific delivery of mirna modulators for the treatment of obesity and related disorders
02/06/2014WO2014022841A1 Cyclodextrin for the treatment of lysosomal storage diseases
02/06/2014WO2014022839A1 Exocylic nitrogen atom protected nucloside and method for producing and using the same
02/06/2014WO2014022830A2 Human papilloma virus as predictor of cancer prognosis
02/06/2014WO2014022816A2 Pharmaceutical compositions comprising 15-hetre and methods of treating or preventing arthritis using same
02/06/2014WO2014022807A2 Compositions and methods of using the compositions for plaque softening
02/06/2014WO2014022772A1 Tomatidine, analogs thereof, compositions comprising same, and uses for same
02/06/2014WO2014022767A1 Dihydropyridone p1 as factor xia inhibitors
02/06/2014WO2014022766A1 Dihydropyridone p1 as factor xia inhibitors
02/06/2014WO2014022752A1 Macrocycles as pim inhibitors
02/06/2014WO2014022748A1 The use of antithrombin in extracorporeal membrane oxygenation
02/06/2014WO2014022744A1 INDOLE-SUBSTITUTED PYRROLOPYRIMIDINYL INHIBITORS OF Uba6
02/06/2014WO2014022728A1 Substituted 5 - (quinazolin - 2 - yl) pyrimidin- 2 -amine derivatives useful as pi3k/mtor inhibitors for the treatment of cancer
02/06/2014WO2014022660A1 Curcumin analogs and methods of making and using thereof
02/06/2014WO2014022639A1 Solid forms of (4-isopropoxy-3-methoxyphenyl)(2'-methyl-6'-(trifluoromethyl)-3',4'-dihydro-2'h-spiro[piperidine-4,1'-pyrrolo[1,2-a]pyrazine]-1-yl)methanone
02/06/2014WO2014022636A1 Broad spectrum inhibitors of the post proline cleaving enzymes for treatment of hepatitis c virus infections
02/06/2014WO2014022613A1 Antibacterial compositions and methods
02/06/2014WO2014022577A1 N-alkyl 2-(disubstituted)alkynyladenosine-5-uronamides as a2a agonists
02/06/2014WO2014022570A1 Treating pain in patients with hepatic impairment
02/06/2014WO2014022569A1 Treatment of dry eye
02/06/2014WO2014022528A1 Antidiabetic tricyclic compounds
02/06/2014WO2014022501A2 Strain-promoted crosslinking of peg-based hydrogels via copper-free cycloaddition
02/06/2014WO2014022390A1 Deuterated ibrutinib
02/06/2014WO2014022382A2 Antibacterial protein kinase inhibitors
02/06/2014WO2014022376A2 Treatment of pulmonary arterial hypertension with prostacyclin-treated endothelial progenitor cells
02/06/2014WO2014022373A1 Treatment of pulmonary arterial hypertension with mesenchymal stem cells
02/06/2014WO2014022349A1 7-hydroxy-spiropipiperidine indolinyl antagonists of p2y1 receptor
02/06/2014WO2014022343A1 7-hydroxy-indolinyl antagonists of p2y1 receptor
02/06/2014WO2014022291A1 Compounds reducing the production of sorbitol in the eye and methods of using the same
02/06/2014WO2014022287A1 Antagonists of the toll-like receptor 1/2 complex
02/06/2014WO2014022279A1 Compositions and methods for reducing blood alcohol content
02/06/2014WO2014022277A1 Zinc chelating agents for depleting xiap and sensitizing tumor cells to apoptosis
02/06/2014WO2014022253A1 Amino-heteroaryl 7-hydroxy-spiropiperidine indolinyl antagonists of p2y1 receptor
02/06/2014WO2014022237A1 Amorphous cabazitaxel
02/06/2014WO2014022167A1 Aryl lactam kinase inhibitors
02/06/2014WO2014022143A1 Orl-1 receptor antagonists for the treatment of anxiety
02/06/2014WO2014022139A1 Methods for identifying agents for treating smooth muscle disorders and compositions thereof
02/06/2014WO2014022128A1 Pi3 kinase modulators and methods of use
02/06/2014WO2014022117A1 Substituted pyrazolone compounds and methods of use
02/06/2014WO2014022116A2 Substituted pyrazolone compounds and methods of use
02/06/2014WO2014021844A1 Alkyl ether compositions and methods of use
02/06/2014WO2014021804A1 A method for increasing meat and milk production
02/06/2014WO2014021803A1 Use of olanzapine in animals
02/06/2014WO2014021802A1 Use of fluoxetine for increasing meat and milk production
02/06/2014WO2014021801A1 Use of fluoxetine in animals
02/06/2014WO2014021694A1 Composition for preventing and treating bone-related diseases
02/06/2014WO2014021678A1 Microbubble-nanoliposome complex for cancer diagnosis and treatment
02/06/2014WO2014021667A1 Composition for treating cancer associated with hpv infection
02/06/2014WO2014021637A1 Composition comprising rebamipide as active ingredient for preventing or treating hyperlipemia and diseases associated therewith
02/06/2014WO2014021591A2 Novel compound, method for preparing same and pharmaceutical composition comprising same
02/06/2014WO2014021468A1 Amide compound
02/06/2014WO2014021464A1 Hydroxylated krn7000 analogue and use thereof
02/06/2014WO2014021455A1 Immune cell activation inhibitor and use thereof
02/06/2014WO2014021408A1 Method for treating cancer by anticancer agent co-administration
02/06/2014WO2014021404A1 Use of ethanolamine phosphoric acid
1 ... 388 389 390 391 392 393 394 395 396 397 398 399 400 401 402 403 404 405 406 407 408 ... 7860